Key facts
- This page summarizes Chad M. Nikel's Form 3 filing for HAEMONETICS CORP (HAE).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 16 Aug 2021, 16:15.
Chad M. Nikel - 06 Aug 2021 Form 3 Insider Report for HAEMONETICS CORP (HAE)
- Reporting relationship
- President, Global Plasma & BC
- Issuer ticker
- HAE
- Reported as of
- 06 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Thomas V. Powers, attorney-in-fact for Mr. Nikel
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Chad M. Nikel filed Form 3 for HAEMONETICS CORP (HAE) on 16 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HAE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,336
- Date
- 06 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HAE
holding
Derivative
Non-qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,966
- Exercise price
- $56.57
- Footnotes
- F2
HAE
holding
Derivative
Non-qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,319
- Exercise price
- $103.37
- Footnotes
- F3
HAE
holding
Derivative
Non-qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,342
- Exercise price
- $98.02
- Footnotes
- F4
HAE
holding
Derivative
Non-qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,282
- Exercise price
- $93.52
- Footnotes
- F5
HAE
holding
Derivative
Non-qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,968
- Exercise price
- $41.64
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
12,187 securities are in the form of unvested restricted stock units ("RSUs") issued pursuant to the Issuer's 2005 Long-Term Incentive Compensation Plan (as amended) or 2019 Long-Term Incentive Compensation Plan. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. 5,559 of such RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant, with shares vesting on various dates between May 2022 and May 2025. 6,628 of such RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant, with shares vesting in May 2022 and May 2023.
Footnote F2
Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Footnote F3
Reflects options granted on May 18, 2020 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Footnote F4
Reflects options granted on May 14, 2019 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Footnote F5
Reflects options granted on June 11, 2018 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Footnote F6
Reflects options granted on June 6, 2017 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.